Literature DB >> 8890401

Interaction of urinary crystals with renal epithelial cells in the pathogenesis of nephrolithiasis.

J C Lieske1, F G Toback.   

Abstract

Renal tubular fluid in the distal nephron is supersaturated with calcium and oxalate ions that nucleate to form crystals of calcium oxalate monohydrate (COM), the most common crystal in renal stones. It is not known how these nascent crystals are retained in the nephron to form calculi in certain individuals. Recent studies from this laboratory indicate that COM crystals can bind within seconds to anionic, sialic acid-containing glycoproteins on the apical surface of kidney epithelial cells in culture, suggesting one mechanisms whereby crystals could be retained in the tubule. Adherence of crystals to renal epithelial cells is inhibited by specific urinary anions such as glycosaminoglycans, uropontin, nephrocalcin, and citrate, each of which binds to the crystalline surface. Thus competition for the crystal surface between soluble anions in tubular fluid and anions on the apical cell surface could determine whether or not a crystal binds to the cell. Once bound, crystals are quickly internalized by renal cells in culture; reorganization of the cytoskeleton, alterations in gene expression, and initiation of proliferation can then ensue. Each of these cellular events appears to be regulated by a different set of extracellular factors. Identification of molecules in tubular fluid and on the cell surface that modulate crystal-cell interactions, as well as their mechanism of action, appears critical for understanding the pathogenesis of nephrolithiasis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890401

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  9 in total

1.  In vitro crystallisation systems for the study of urinary stone formation.

Authors:  W Achilles
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

2.  Nephrolithiasis in a worker with cadmium exposure in the past.

Authors:  Andrea Trevisan; Claudio Gardin
Journal:  Int Arch Occup Environ Health       Date:  2005-10-12       Impact factor: 3.015

3.  Effects of luminal oxalate or calcium oxalate on renal tubular cells in culture.

Authors:  C F Verkoelen; M S J Schepers; E S van Ballegooijen; C H Bangma
Journal:  Urol Res       Date:  2005-11-13

4.  The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients.

Authors:  Jose A Meneses; Fernando M Lucas; Fernando C Assunção; Junia P P Castro; Rogério B Monteiro
Journal:  Urol Res       Date:  2011-08-20

5.  Evaluation of histologic changes in the urinary tract of hypercalciuric rats.

Authors:  Ipek Akil; Salih Kavukçu; Sevinç Inan; Osman Yilmaz; Pergin Atilla; Hüray Işlekel; Nalan Neşe; Sevda Müftüoğlu
Journal:  Pediatr Nephrol       Date:  2006-08-22       Impact factor: 3.714

6.  Proteolysis and partial dissolution of calcium oxalate: a comparative, morphological study of urinary crystals from black and white subjects.

Authors:  Dawn Webber; Magali C Chauvet; Rosemary L Ryall
Journal:  Urol Res       Date:  2005-05-05

7.  Kidney stone inhibitors in patients with renal stones and endemic renal tubular acidosis in northeast Thailand.

Authors:  Yasushi Nakagawa; Mauricio Carvalho; Prida Malasit; Sumalee Nimmannit; Suchai Sritippaywan; Somkiat Vasuvattakul; Somchai Chutipongtanate; Vipada Chaowagul; Sanga Nilwarangkur
Journal:  Urol Res       Date:  2004-02-03

8.  Oligomeric proanthocyanidins protect against HK-2 cell injury induced by oxalate and calcium oxalate monohydrate crystals.

Authors:  Shuo Wang; Peng Du; Ning Zhang; Jia Liu; Xingxing Tang; Qiang Zhao; Yong Yang
Journal:  Urolithiasis       Date:  2015-10-07       Impact factor: 3.436

9.  Dietary Oxalate Induces Urinary Nanocrystals in Humans.

Authors:  Parveen Kumar; Mikita Patel; Vinoy Thomas; John Knight; Ross P Holmes; Tanecia Mitchell
Journal:  Kidney Int Rep       Date:  2020-05-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.